ProT-096
/ Protgen
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 13, 2026
Cellares and ProTgen Automate Manufacturing of Progenitor T-Cell Therapy for Blood Cancer
(Genengnews)
- "In this collaboration, Cellares will apply the company’s Cell Shuttle and Cell Q platforms to ProT-096 while providing regulatory support toward IND submission."
Licensing / partnership • Leukemia
1 to 1
Of
1
Go to page
1